About RAC
Racura Oncology (RAC) is a Phase 3 clinical biopharmaceutical company with a mission to be at the heart of cancer care.
Find out what a historical investment in Racura Oncology would be worth today using our RAC stock calculator.
Market Capitalisation
$350.96M
Price-earnings ratio
-28.92
Dividend yield
-
High today
$1.82
Low today
$1.80
Open price
$1.82
52-week high
$4.90
52-week low
$1.77
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RAC
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in RAC on Stake
- Buy RAC from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
RAC related stocks